Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Alfredsson

Showing results (311-320 of 466) with videos related to

Pageof 47
Sort By:
Obesity Research & Clinical Practice|September 30, 2014
Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factorsMilena A Gianfrancesco, Brigid Acuna, Ling Shen, et al.
Arthritis and Rheumatism|June 30, 2007
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritisSnaevar Sigurdsson, Leonid Padyukov, Fina A S Kurreeman, et al.
Epidemiology (Cambridge, Mass.)|March 15, 2014
Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variantsFarren B S Briggs, Brigid Acuna, Ling Shen, et al.
American Journal of Human Genetics|December 29, 2005
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4Robert M Plenge, Leonid Padyukov, Elaine F Remmers, et al.
Annals of the Rheumatic Diseases|December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammationEleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Rheumatology (Oxford, England)|October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritisHelga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
International Journal of Cancer|May 10, 2017
Use of moist oral snuff (snus) and pancreatic cancer: Pooled analysis of nine prospective observational studiesMarzieh Araghi, Maria Rosaria Galanti, Michael Lundberg, et al.
Neurology|February 13, 2020
Blood neurofilament light levels segregate treatment effects in multiple sclerosisBénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, et al.
Science Advances|May 17, 2023
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosisOlivia G Thomas, Mattias Bronge, Katarina Tengvall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammationAmennai D Beyeen, Milena Z Adzemovic, Johan Ockinger, et al.
Pageof 47

Showing results (311-320 of 466) with videos related to

Sort By:
Pageof 47
Obesity Research & Clinical Practice|September 30, 2014
Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factorsMilena A Gianfrancesco, Brigid Acuna, Ling Shen, et al.
Arthritis and Rheumatism|June 30, 2007
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritisSnaevar Sigurdsson, Leonid Padyukov, Fina A S Kurreeman, et al.
Epidemiology (Cambridge, Mass.)|March 15, 2014
Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variantsFarren B S Briggs, Brigid Acuna, Ling Shen, et al.
American Journal of Human Genetics|December 29, 2005
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4Robert M Plenge, Leonid Padyukov, Elaine F Remmers, et al.
Annals of the Rheumatic Diseases|December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammationEleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Rheumatology (Oxford, England)|October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritisHelga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
International Journal of Cancer|May 10, 2017
Use of moist oral snuff (snus) and pancreatic cancer: Pooled analysis of nine prospective observational studiesMarzieh Araghi, Maria Rosaria Galanti, Michael Lundberg, et al.
Neurology|February 13, 2020
Blood neurofilament light levels segregate treatment effects in multiple sclerosisBénédicte Delcoigne, Ali Manouchehrinia, Christian Barro, et al.
Science Advances|May 17, 2023
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosisOlivia G Thomas, Mattias Bronge, Katarina Tengvall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2010
IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammationAmennai D Beyeen, Milena Z Adzemovic, Johan Ockinger, et al.
Pageof 47